Exagen
XGN
Exagen (XGN) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.13
- EPS estimate
- −$0.19
- EPS surprise
- +32.08%
- Revenue surprise
- +12.03%
- Revenue
- $19.9M
- Revenue estimate
- $17.8M
- Reported
- Aug 4, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 4, 2026 | −$0.19 | −$0.13 | +32.08% | $19.9M | SEC |
| Q1 2026 | May 11, 2026 | −$0.23 | −$0.17 | +27.01% | $17.3M | SEC |
| Q4 2025 | Mar 10, 2026 | −$0.19 | −$0.20 | −5.43% | $16.6M | SEC |
| Q3 2025 | Nov 4, 2025 | −$0.16 | −$0.31 | −97.58% | $17.2M | SEC |
| Q2 2025 | Jul 29, 2025 | −$0.15 | −$0.21 | −40.00% | $17.2M | SEC |
| Q1 2025 | May 5, 2025 | −$0.20 | −$0.20 | +1.09% | $15.5M | SEC |
| Q4 2024 | Mar 11, 2025 | −$0.26 | −$0.20 | +21.88% | $13.7M | SEC |
| Q3 2024 | Nov 12, 2024 | −$0.29 | −$0.28 | +3.38% | $12.5M | SEC |
| Q2 2024 | Aug 5, 2024 | −$0.34 | −$0.16 | +52.94% | $15.1M | SEC |
| Q1 2024 | May 13, 2024 | −$0.36 | −$0.19 | +47.35% | $14.4M | SEC |
| Q4 2023 | Mar 18, 2024 | −$0.43 | −$0.31 | +27.99% | $13.8M | SEC |
| Q3 2023 | Nov 13, 2023 | −$0.47 | −$0.31 | +34.03% | $13.4M | SEC |
| Q2 2023 | Aug 7, 2023 | −$0.50 | −$0.28 | +43.51% | $14.1M | SEC |
| Q1 2023 | May 15, 2023 | −$0.56 | −$0.44 | +21.68% | $11.2M | SEC |
| Q4 2022 | Mar 20, 2023 | −$0.77 | −$0.83 | −8.20% | $12.8M | SEC |
| Q3 2022 | Nov 14, 2022 | −$0.77 | −$0.47 | +38.70% | $14.7M | SEC |
| Q2 2022 | Aug 4, 2022 | −$0.57 | −$0.78 | −37.06% | $9.0M | SEC |
| Q1 2022 | May 11, 2022 | −$0.61 | −$0.60 | +1.36% | $10.4M | SEC |
| Q4 2021 | Mar 22, 2022 | −$0.48 | −$0.42 | +12.59% | $12.7M | SEC |
| Q3 2021 | Nov 10, 2021 | −$0.46 | −$0.42 | +8.70% | $12.3M | SEC |
Quarterly revenue
Frequently asked questions
When did Exagen (XGN) last report earnings?
Exagen last reported on Aug 4, 2026, covering fiscal Q2 2026.
Did XGN beat earnings estimates?
Yes. Exagen reported EPS of −$0.13 for Q2 2026 against a −$0.19 estimate — a 32.08% beat.
How much revenue did XGN report last quarter?
Exagen reported $19.9M in revenue for Q2 2026, against a consensus estimate of $17.8M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.